Wacker Builds Biologics

Wacker Chemie says it will develop its biologics operation at Jena, Germany as part of a strategy to expand the company’s fine chemicals business. The Jena facility specializes in using microbial systems, mainly E-coli, for the production of biologics. Wacker is investing about €15 million ($20 million) to expand the operation including a recently opened new process-development unit for pharmaceutical proteins. The company also will double the size of its Jena GMP production facility for biopharmaceuticals by year-end. Wacker has pulled out of contract...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers